Theia Biosciences Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Theia Biosciences General Information
Description
Developer of drug based in San Francisco, California. The company develops small molecule inhibitors of the HTRA1 protein as a potential first-in-class treatment for the wet form and potentially also the dry form of AMD.
Contact Information
Corporate Office
- San Francisco, CA 94103
- United States
Corporate Office
- San Francisco, CA 94103
- United States
Theia Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Theia Biosciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Theia Biosciences FAQs
-
When was Theia Biosciences founded?
Theia Biosciences was founded in 2020.
-
Where is Theia Biosciences headquartered?
Theia Biosciences is headquartered in San Francisco, CA.
-
What industry is Theia Biosciences in?
Theia Biosciences’s primary industry is Drug Discovery.
-
Is Theia Biosciences a private or public company?
Theia Biosciences is a Private company.
-
What is Theia Biosciences’s current revenue?
The current revenue for Theia Biosciences is .
-
Who are Theia Biosciences’s investors?
Numerion Labs has invested in Theia Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
